CytoMed Therapeutics Ltd (GDTC)
2.24
+0.02
(+0.90%)
USD |
NASDAQ |
Nov 14, 16:00
2.24
0.00 (0.00%)
After-Hours: 20:00
CytoMed Therapeutics Total Assets (Quarterly): 8.040M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 8.040M |
| June 30, 2024 | 8.040M |
| December 31, 2023 | 9.365M |
| June 30, 2023 | 10.26M |
| June 30, 2023 | 10.26M |
| Date | Value |
|---|---|
| December 31, 2022 | 3.898M |
| June 30, 2022 | 3.700M |
| June 30, 2022 | 3.700M |
| December 31, 2021 | 4.498M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
3.700M
Minimum
Jun 2022
10.26M
Maximum
Jun 2023
6.862M
Average
8.040M
Median
Jun 2024
Total Assets (Quarterly) Benchmarks
| EUDA Health Holdings Ltd | 2.028M |
| Raffles Medical Group Ltd | 1.119B |
| Haw Par Corp Ltd | 2.812B |
| WAVE Life Sciences Ltd | 208.82M |
| Mobile-health Network Solutions | 7.951M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.5518M |
| Shareholders Equity (Quarterly) | 7.489M |